verified — Trust Score 90/100

Original content reviewed

Platform: INSTAGRAM Author: @mindset.therapy --- Caption/Description --- A new cancer treatment developed by Patrick Soon Shiong is gaining attention for how it works with the body instead of against it. The approach, called Anktiva, activates natural killer cells, a type of immune cell that identifies and destroys abnormal cells including cancer. Natural killer cell based therapies are part of a broader field called immunotherapy. Research shows these cells can detect and attack cancer without prior exposure, making them a powerful early defense. Anktiva is currently approved in the United States for a specific type of bladder cancer. In January 2026, Saudi Arabia became the first country in the world to approve it for lung cancer as well, going further than the U.S. FDA. Ongoing trials will determine its long term impact, but it reflects a growing shift toward treatments that support the body’s own immune system. #cancerresearch #immunotherapy #healthinnovation #medicalscience #awareness --- On-Screen Text (OCR) --- PATRICK SOON SHIONG HAS DEVELOPED A TREATMENT THAT TURNS ON THE BODY’S NATURAL KILLER CELLS TO TARGET CANCER CELLS. IT IS APPROVED IN THE U.S., AND SAUDI ARABIA HAS NOW CLEARED IT FOR PUBLIC USE. Published: 2026-04-20T22:56:02.000Z ---VERIFICATION_SUMMARY--- Platform: INSTAGRAM Author: @mindset.therapy --- Caption/Description --- A new cancer treatment developed by Patrick Soon Shiong is gaining attention for how it works with the body instead of against it. The approach, called Anktiva, activates natural killer cells, a type of immune cell that identifies and destroys abnormal cells including cancer. Natural killer cell based therapies are part of a broader field called immunotherapy. Research shows these cells can detect and attack cancer without prior exposure, making them a powerful early defense. Anktiva is currently approved in the United States for a specific type of bladder cancer. In January 2026, Saudi Arabia became the first c

Claims analyzed (4)

1. verified: Patrick Soon Shiong has developed a treatment called Anktiva.
   Patrick Soon-Shiong is the founder and Executive Chairman of ImmunityBio, the company that developed Anktiva (nogapendekin alfa inbakicept).
2. verified: Anktiva activates natural killer cells to target cancer cells.
   Anktiva is an IL-15 receptor superagonist designed to proliferate and activate natural killer (NK) cells and T cells to attack tumors.
3. verified: Anktiva is approved in the U.S. for a specific type of bladder cancer.
   The FDA approved Anktiva on April 22, 2024, for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ.
4. verified: In January 2026, Saudi Arabia became the first country to approve Anktiva for lung cancer.
   The Saudi Food and Drug Authority (SFDA) granted accelerated approval for Anktiva in combination with checkpoint inhibitors for metastatic non-small cell lung cancer on January 14, 2026.

Sources consulted (10)

• vax-before-travel.com — vax-before-travel.com
• fda.gov — fda.gov
• drugs.com — drugs.com
• ImmunityBio Announces FDA Approval of ANKTIVA — ImmunityBio
• Patrick Soon-Shiong, MD - ImmunityBio — ImmunityBio
• Anktiva (nogapendekin alfa inbakicept-pmln) FDA Approval History — Drugs.com
• Saudi FDA Grants Accelerated Approval to ImmunityBio's ANKTIVA for Metastatic NSCLC — ImmunityBio
• SFDA Approves Registration of 'Anktiva' for Treatment of Bladder and Lung Cancer — Saudi Press Agency
• ImmunityBio's Anktiva shows success as combo treatment in NSCLC — Clinical Trials Arena
• Anktiva as a lymphocyte rescue molecule: Unlocking the power of NK cells and T cells — Urology Times

Related verifications

• 
  mostly true — Trust Score 85/100

  instagram · view post ↗

  The claims regarding ginger's benefits for menstrual health are, including multiple peer-reviewed clinical trials and meta-analyses. While the image is AI-generated and the 'two-week' protocol is a si…

• 
  mostly true — Trust Score 79/100

  instagram · view post ↗

  This post is an authentic statement from Dr. Mike Banna (@drmikethe2nd) posted on January 19, 2026. His claims regarding the cost and nutritional profile of the viral 'yogurt cheesecake' hack are, as …

• 
  verified — Trust Score 92/100

  instagram · view post ↗

  The claims in this post are confirmed by 3 sources, including a landmark 2025 study in Nature Aging and multiple 2023-2026 clinical reviews. While the ranking is the author's synthesis, it accurately …

• 
  mostly true — Trust Score 75/100

  instagram · view post ↗

  The core health claim is confirmed by 6 sources including Harvard Health and the National Institutes of Health, based on a long-term study of over 30,000 men. However, the post is mostly true rather t…

• 
  mostly true — Trust Score 65/100

  instagram · view post ↗

  The health and lifestyle claims in this post reported by the NIH and Mayo Clinic, though some are simplified for marketing. However, the post is a high-pressure sales funnel for a coaching program wit…